| Style | Citing Format |
|---|---|
| MLA | Mottaghi P. "Changes in Bone Biological Markers After Treatment of Iranian Diabetic Patients With Pioglitazone: No Relation to Polymorphism of Ppar-Γ (Pro12ala)." Journal of Research in Medical Sciences, vol. 18, no. 4, 2013, pp. 366-367. |
| APA | Mottaghi P (2013). Changes in Bone Biological Markers After Treatment of Iranian Diabetic Patients With Pioglitazone: No Relation to Polymorphism of Ppar-Γ (Pro12ala). Journal of Research in Medical Sciences, 18(4), 366-367. |
| Chicago | Mottaghi P. "Changes in Bone Biological Markers After Treatment of Iranian Diabetic Patients With Pioglitazone: No Relation to Polymorphism of Ppar-Γ (Pro12ala)." Journal of Research in Medical Sciences 18, no. 4 (2013): 366-367. |
| Harvard | Mottaghi P (2013) 'Changes in Bone Biological Markers After Treatment of Iranian Diabetic Patients With Pioglitazone: No Relation to Polymorphism of Ppar-Γ (Pro12ala)', Journal of Research in Medical Sciences, 18(4), pp. 366-367. |
| Vancouver | Mottaghi P. Changes in Bone Biological Markers After Treatment of Iranian Diabetic Patients With Pioglitazone: No Relation to Polymorphism of Ppar-Γ (Pro12ala). Journal of Research in Medical Sciences. 2013;18(4):366-367. |
| BibTex | @article{ author = {Mottaghi P}, title = {Changes in Bone Biological Markers After Treatment of Iranian Diabetic Patients With Pioglitazone: No Relation to Polymorphism of Ppar-Γ (Pro12ala)}, journal = {Journal of Research in Medical Sciences}, volume = {18}, number = {4}, pages = {366-367}, year = {2013} } |
| RIS | TY - JOUR AU - Mottaghi P TI - Changes in Bone Biological Markers After Treatment of Iranian Diabetic Patients With Pioglitazone: No Relation to Polymorphism of Ppar-Γ (Pro12ala) JO - Journal of Research in Medical Sciences VL - 18 IS - 4 SP - 366 EP - 367 PY - 2013 ER - |